Higher BMI May Reduce Chemotherapy Response with Breast Cancer


New research indicates that overweight patients with operable breast cancer are less likely than their normal weight peers to achieve a complete pathologic response to neoadjuvant chemotherapy.

Related Videos
Deepak Bhatt, MD, MPH | Credit: Mount Sinai
Robert Wood, MD | Credit: LinkedIn
Marla Dubinsky, MD | Credit: LinkedIn
Wei Zhang, MD, PhD | Credit: Mass General Brigham
Robert Wood, MD | Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.